IceCure Medical (ICCM) Raw Materials (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Raw Materials data on file, last reported at $1.8 million in Q4 2025.

• Raw Materials for Q4 2025 came in at $1.8 million, up 28.2% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (up 28.2% YoY), and the FY2025 annual result was $1.8 million, up 28.2% from the prior year.
• Raw Materials grew to $1.8 million in Q4 2025 per ICCM's latest filing, from $1.4 million in the prior quarter.
• Over five years, Raw Materials peaked at $1.8 million in Q4 2025 and troughed at $704000.0 in Q4 2021.
• A 5-year average of $1.4 million and a median of $1.4 million in 2024 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2022 and 2023: Raw Materials jumped 122.44% in 2022, then slipped 11.17% in 2023.
• A 5-year view of Raw Materials shows it stood at $704000.0 in 2021, then soared by 122.44% to $1.6 million in 2022, then fell by 11.17% to $1.4 million in 2023, then rose by 1.22% to $1.4 million in 2024, then advanced by 28.2% to $1.8 million in 2025.
• Business Quant data shows ICCM's Raw Materials at $1.8 million in Q4 2025, $1.4 million in Q4 2024, and $1.4 million in Q4 2023.